{"id":9376,"date":"2026-03-09T12:24:00","date_gmt":"2026-03-09T12:24:00","guid":{"rendered":"https:\/\/stoxpo.com\/?p=9376"},"modified":"2026-03-09T12:24:00","modified_gmt":"2026-03-09T12:24:00","slug":"hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk","status":"publish","type":"post","link":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/","title":{"rendered":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk"},"content":{"rendered":"\n<h4 class=\"wp-block-heading\">Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Shares of Hims &amp; Hers Health (HIMS) surged more than 50% after the telehealth company announced a new partnership with pharmaceutical giant Novo Nordisk (NVO) to distribute blockbuster obesity medications such as Wegovy and Ozempic. The announcement marks a significant turning point for the company, which had previously been entangled in a legal dispute with Novo Nordisk related to the sale and promotion of similar treatments.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The agreement allows Hims &amp; Hers to offer the widely sought-after weight-loss medications through its digital health platform, expanding access for patients seeking treatment for obesity and related metabolic conditions. Demand for GLP-1 drugs like Wegovy and Ozempic has surged globally as these medications have demonstrated strong effectiveness in helping patients lose weight and manage diabetes.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The partnership represents a strategic pivot for Hims &amp; Hers as it seeks to position itself within one of the fastest-growing segments of the healthcare market. By integrating Novo Nordisk\u2019s medications into its telehealth model, the company aims to streamline patient consultations, prescriptions, and delivery through its online platform.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Investors responded enthusiastically to the news, sending the company\u2019s stock sharply higher as markets interpreted the deal as validation of Hims &amp; Hers\u2019 expanding role in digital healthcare distribution. The collaboration could significantly broaden the company\u2019s revenue opportunities, particularly as obesity treatments continue to see explosive global demand.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">However, the development also comes at a time when telehealth platforms face increased regulatory scrutiny over how prescription medications are marketed and distributed online. Analysts remain divided on the long-term outlook, with some praising the partnership as a major growth catalyst while others caution that regulatory challenges and competition in the weight-loss drug market could limit future gains.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Still, the agreement signals that both companies are willing to move past earlier conflicts and pursue a collaborative strategy aimed at capturing a share of the booming obesity treatment market.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">You might like this article:<a href=\"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/gold-retreats-as-stronger-dollar-and-rising-oil-pressure-markets\/\"><mark style=\"background-color:rgba(0, 0, 0, 0)\" class=\"has-inline-color has-vivid-cyan-blue-color\">Gold Retreats as Stronger Dollar and Rising Oil Pressure Markets<\/mark><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims &amp; Hers Health (HIMS) surged more than 50% after the telehealth company announced a new partnership with pharmaceutical giant Novo Nordisk (NVO) to distribute blockbuster obesity medications such as Wegovy and Ozempic. The announcement marks a significant turning point [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1125,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jnews-multi-image_gallery":[],"jnews_single_post":[],"jnews_primary_category":[],"jnews_social_meta":[],"jnews_override_counter":[],"jnews_post_split":[],"footnotes":""},"categories":[308,361,309],"tags":[421,662,416,418,543,417],"coauthors":[454],"class_list":["post-9376","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-biotechnology","category-large-cap","category-pharmaceuticals","tag-growth","tag-hims","tag-movers","tag-news","tag-nvo","tag-stock-market"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo\" \/>\n<meta property=\"og:description\" content=\"Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims &amp; Hers Health (HIMS) surged more than 50% after the telehealth company announced a new partnership with pharmaceutical giant Novo Nordisk (NVO) to distribute blockbuster obesity medications such as Wegovy and Ozempic. The announcement marks a significant turning point [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/\" \/>\n<meta property=\"og:site_name\" content=\"Stoxpo\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-09T12:24:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Luca Blaumann\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Luca Blaumann\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/\"},\"author\":{\"name\":\"Luca Blaumann\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\"},\"headline\":\"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk\",\"datePublished\":\"2026-03-09T12:24:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/\"},\"wordCount\":348,\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3873143-scaled.jpg\",\"keywords\":[\"Growth\",\"HIMS\",\"Movers\",\"News\",\"NVO\",\"Stock Market\"],\"articleSection\":[\"Biotechnology\",\"Large-Cap\",\"Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/\",\"name\":\"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3873143-scaled.jpg\",\"datePublished\":\"2026-03-09T12:24:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#primaryimage\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3873143-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/pexels-polina-tankilevitch-3873143-scaled.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"drugs-5\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/2026\\\/03\\\/09\\\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/stoxpo.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#website\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"name\":\"Stoxpo\",\"description\":\"Stock Market &amp; Financial News\",\"publisher\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/stoxpo.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#organization\",\"name\":\"Stoxpo\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"contentUrl\":\"https:\\\/\\\/stoxpo.com\\\/wp-content\\\/uploads\\\/2024\\\/02\\\/4q4p91-LogoMakr.png\",\"width\":250,\"height\":250,\"caption\":\"Stoxpo\"},\"image\":{\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/stoxpo.com\\\/#\\\/schema\\\/person\\\/031a96817fc4447b1046e0a10baad806\",\"name\":\"Luca Blaumann\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g\",\"caption\":\"Luca Blaumann\"},\"description\":\"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.\",\"url\":\"https:\\\/\\\/stoxpo.com\\\/index.php\\\/author\\\/luca-blaumann\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/","og_locale":"en_US","og_type":"article","og_title":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo","og_description":"Telehealth company pivots toward weight-loss drug market following legal dispute and regulatory scrutiny Shares of Hims &amp; Hers Health (HIMS) surged more than 50% after the telehealth company announced a new partnership with pharmaceutical giant Novo Nordisk (NVO) to distribute blockbuster obesity medications such as Wegovy and Ozempic. The announcement marks a significant turning point [&hellip;]","og_url":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/","og_site_name":"Stoxpo","article_published_time":"2026-03-09T12:24:00+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg","type":"image\/jpeg"}],"author":"Luca Blaumann","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Luca Blaumann","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#article","isPartOf":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/"},"author":{"name":"Luca Blaumann","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806"},"headline":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk","datePublished":"2026-03-09T12:24:00+00:00","mainEntityOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/"},"wordCount":348,"publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg","keywords":["Growth","HIMS","Movers","News","NVO","Stock Market"],"articleSection":["Biotechnology","Large-Cap","Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/","url":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/","name":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk - Stoxpo","isPartOf":{"@id":"https:\/\/stoxpo.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#primaryimage"},"image":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#primaryimage"},"thumbnailUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg","datePublished":"2026-03-09T12:24:00+00:00","breadcrumb":{"@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#primaryimage","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/pexels-polina-tankilevitch-3873143-scaled.jpg","width":2560,"height":1707,"caption":"drugs-5"},{"@type":"BreadcrumbList","@id":"https:\/\/stoxpo.com\/index.php\/2026\/03\/09\/hims-hers-stock-soars-after-strategic-partnership-with-novo-nordisk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/stoxpo.com\/"},{"@type":"ListItem","position":2,"name":"Hims &amp; Hers Stock Soars After Strategic Partnership With Novo Nordisk"}]},{"@type":"WebSite","@id":"https:\/\/stoxpo.com\/#website","url":"https:\/\/stoxpo.com\/","name":"Stoxpo","description":"Stock Market &amp; Financial News","publisher":{"@id":"https:\/\/stoxpo.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/stoxpo.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/stoxpo.com\/#organization","name":"Stoxpo","url":"https:\/\/stoxpo.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/","url":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","contentUrl":"https:\/\/stoxpo.com\/wp-content\/uploads\/2024\/02\/4q4p91-LogoMakr.png","width":250,"height":250,"caption":"Stoxpo"},"image":{"@id":"https:\/\/stoxpo.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/stoxpo.com\/#\/schema\/person\/031a96817fc4447b1046e0a10baad806","name":"Luca Blaumann","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g90dbb3a40c7379bca26d2b3dc92b368b","url":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b7bbde6ef0582da5f93c9ff12262ea37de640f314250f9e3cfaeb37e258a563a?s=96&d=mm&r=g","caption":"Luca Blaumann"},"description":"Luca is a proficient stock market reporter with a passion for dissecting complex market dynamics and uncovering transformative industry developments. With years of experience in leading editorial teams and overseeing coverage of the stock market and publicly traded companies, Luca has honed the ability to translate finance jargon into easily digestible articles. For tips and inquiries, reach out to Luca at tips@stoxpo.com.","url":"https:\/\/stoxpo.com\/index.php\/author\/luca-blaumann\/"}]}},"_links":{"self":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/9376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/comments?post=9376"}],"version-history":[{"count":1,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/9376\/revisions"}],"predecessor-version":[{"id":9377,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/posts\/9376\/revisions\/9377"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media\/1125"}],"wp:attachment":[{"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/media?parent=9376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/categories?post=9376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/tags?post=9376"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/stoxpo.com\/index.php\/wp-json\/wp\/v2\/coauthors?post=9376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}